- Home
- SINT vs VYNE Comparison
SINT vs VYNE Comparison
Compare SINT & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SINT
- VYNE
- Stock Information
- Founded
- SINT 1996
- VYNE 2003
- Country
- SINT United States
- VYNE United States
- Employees
- SINT N/A
- VYNE N/A
- Industry
- SINT Medical/Dental Instruments
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- SINT Health Care
- VYNE Health Care
- Exchange
- SINT Nasdaq
- VYNE Nasdaq
- Market Cap
- SINT 11.6M
- VYNE 9.6M
- IPO Year
- SINT 2014
- VYNE 2018
- Fundamental
- Price
- SINT $3.74
- VYNE $0.37
- Analyst Decision
- SINT Strong Buy
- VYNE Buy
- Analyst Count
- SINT 1
- VYNE 2
- Target Price
- SINT $25.00
- VYNE $8.00
- AVG Volume (30 Days)
- SINT 440.1K
- VYNE 3.1M
- Earning Date
- SINT 11-11-2025
- VYNE 11-10-2025
- Dividend Yield
- SINT N/A
- VYNE N/A
- EPS Growth
- SINT N/A
- VYNE N/A
- EPS
- SINT N/A
- VYNE N/A
- Revenue
- SINT $1,861,000.00
- VYNE $476,000.00
- Revenue This Year
- SINT N/A
- VYNE N/A
- Revenue Next Year
- SINT $80.00
- VYNE N/A
- P/E Ratio
- SINT N/A
- VYNE N/A
- Revenue Growth
- SINT N/A
- VYNE N/A
- 52 Week Low
- SINT $1.71
- VYNE $0.28
- 52 Week High
- SINT $8.60
- VYNE $4.30
- Technical
- Relative Strength Index (RSI)
- SINT 46.38
- VYNE 49.90
- Support Level
- SINT $3.10
- VYNE $0.34
- Resistance Level
- SINT $4.13
- VYNE $0.39
- Average True Range (ATR)
- SINT 0.41
- VYNE 0.04
- MACD
- SINT -0.09
- VYNE 0.00
- Stochastic Oscillator
- SINT 42.19
- VYNE 30.38
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.